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BACKGROUND: Despite in-depth knowledge of the molecular 
mechanisms controlling embryonic heart development, little is known 
about the signals governing postnatal maturation of the human heart.
METHODS: Single-nucleus RNA sequencing of 54 140 nuclei from 9 
human donors was used to profile transcriptional changes in diverse 
cardiac cell types during maturation from fetal stages to adulthood. Bulk 
RNA sequencing and the Assay for Transposase-Accessible Chromatin 
using sequencing were used to further validate transcriptional changes 
and to profile alterations in the chromatin accessibility landscape in 
purified cardiomyocyte nuclei from 21 human donors. Functional 
validation studies of sex steroids implicated in cardiac maturation were 
performed in human pluripotent stem cell–derived cardiac organoids 
and mice.
RESULTS: Our data identify the progesterone receptor as a key mediator 
of sex-dependent transcriptional programs during cardiomyocyte 
maturation. Functional validation studies in human cardiac organoids 
and mice demonstrate that the progesterone receptor drives sex-specific 
metabolic programs and maturation of cardiac contractile properties.
CONCLUSIONS: These data provide a blueprint for understanding human 
heart maturation in both sexes and reveal an important role for the 
progesterone receptor in human heart development.
Sex-Specific Control of Human Heart 
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Heart development begins in the embryo and con-tinues into adulthood to establish the mature gene expression programs that sustain cardiac 
output throughout life. The human heart undergoes 
profound changes in many facets of cardiac physiology 
after birth, including increased contractility and shifts in 
metabolic substrate use to adapt to the increased oxy-
gen perfusion and growth demands of the postnatal 
environment.1,2 Although the molecular mechanisms 
governing embryonic development in vertebrates have 
been intensively interrogated, little is known about the 
mechanisms controlling postnatal maturation and the 
acquisition of adult cell identity in mammals.1 Although 
recent studies have begun to provide a transcriptional 
framework for cardiac development and disease at the 
single-cell level,3–7 the mechanisms regulating postna-
tal heart maturation in humans have not been defined. 
Moreover, recent single-cell transcriptomic studies have 
identified sexually dimorphic gene expression programs 
in adult mice8 and humans,7 suggesting that cardiac 
identity and cellularity are dependent on biological sex 
and regulated by gonadal hormones.9 However, despite 
well-documented sex differences in cardiovascular 
physiology and disease outcomes,10,11 the transcription-
al mechanisms governing the emergence of sex-specific 
gene expression programs during human heart devel-
opment are unknown.
METHODS
Please refer to the Data Supplement Methods and Tables I–IV 
for a full description of experimental procedures.
Human Ethics and Tissue Collection
Human ethics for cardiac tissue biobanking and human pluripo-
tent stem cell research was approved by The Royal Children’s 
Hospital Melbourne Human Research Ethics Committee (approval 
numbers: HREC 38192, HREC 33001A, HREC 37172A, HREC 
36358A), The University of Queensland Institutional Human 
Research Ethics Committee (SBS/2014000329), QIMR Berghofer 
Human Research Ethics Committee (P2385), and The University 
of Sydney Human Research Ethics Committee (HREC 2016/923). 
Fetal tissues were procured from Advanced Bioscience Resources 
(CA). Informed consent was obtained from all human subjects, 
and studies were conducted in accordance with the approved 
protocols and guidelines from the National Health and Medical 
Research Council of Australia. All human heart specimens (apical 
region of left ventricle) were obtained from donor hearts with-
out any clinical evidence of cardiovascular disease and stored in 
liquid nitrogen (Table V in the Data Supplement).
Animal Ethics and Tissue Collection
Animal experiments were conducted in accordance with the 
relevant codes of practice for the care and use of animals for 
scientific purposes as stipulated by the National Health and 
Medical Research Council of Australia and conducted with 
approval from the Animal Ethics Committees of the Alfred 
Medical Research and Education Precinct (E/1706/2017/B) 
and The University of Adelaide (M 2018-122). For neonatal 
recombinant adeno-associated viral vector (AAV) injection 
experiments, C57BL/6J mice were maintained in a 12-hour 
light:dark cycle at a temperature of 22±1 °C and provided ad 
libitum access to food and water during the study duration. 
At postnatal day 1, male and female C57BL/6J mice received a 
single intraperitoneal injection of AAV serotype 6 vectors con-
taining either the longest isoform of the full-length human 
progesterone receptor (PGR) sequence NM_000926.4 (AAV_
PGR) or a negative control AAV lacking a sequence insert in 
the multiple cloning site (AAV_Con), under the control of the 
human cytomegalovirus promoter. All animals were treated 
with 1×1012 vector genomes resuspended in a total volume of 
50 μL of PBS. Neonates were weaned between 21 and 28 days 
of age. PRKO (Pgrtm1Bwo knockout) mice were obtained from 
The Jackson Laboratory and maintained at The University of 
Adelaide under a 12-hour light:dark cycle at a temperature of 
22±1 °C with ad libitum access to food and water during the 
study duration. For both AAV and PRKO mice studies, male 
and female adult mice were humanely euthanized by cervi-
cal dislocation at postnatal day 56, and the heart was rapidly 
excised. Atrial tissues were removed from ventricles (septum 
intact), and ventricles were collected and snap-frozen in liquid 
nitrogen for storage at –80 °C until processing.
Clinical Perspective
What Is New?
• Recent advances in single-cell sequencing are pro-
viding an unprecedented view of cellular hetero-
geneity in the healthy and diseased human heart.
• We performed single nucleus RNA sequencing to 
capture transcriptional changes across multiple car-
diac cell populations during human heart develop-
ment from fetal stages to adulthood.
• Our data reveal sex-specific transcriptional mecha-
nisms governing maturation of multiple cell types 
in the heart, including a previously unrecognized 
role for the progesterone receptor in human car-
diomyocyte maturation.
What Are the Clinical Implications?
• Despite well-documented sex differences in car-
diovascular physiology and disease outcomes, the 
transcriptional mechanisms driving the emergence 
of sex-specific human cardiac biology remain 
largely unknown.
• Our findings uncover sex-specific functions of the 
progesterone receptor in the regulation of cardio-
myocyte metabolism in males and females, thus 
raising the possibility that progesterone signaling 
could be therapeutically targeted to modify sexu-
ally dimorphic disease outcomes in the future.
• The potential direct effects of progesterone on 
the heart should be considered with respect to 
cardiovascular adaptations during pregnancy and 
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Cardiac nuclei were isolated as described previously,12 with 
minor modifications. For single-nucleus RNA sequencing 
(RNA-seq [snRNA-seq]), ≈20 to 100 mg of human left ventric-
ular tissue were used per sample, whereas ≈0.5 to 1.0 g of tis-
sue was required for bulk RNA-seq of purified cardiomyocyte 
nuclei (mouse and human).12 All steps were conducted on ice.
SnRNA-Seq Library Preparation and 
Sequencing
Isolated nuclei were stained with Hoechst 33342 (Thermo 
Fisher Scientific) before sorting on an Influx cell sorter (Becton 
Dickinson) with a 70-µmol/L nozzle and 60 psi pressure setting. 
Sorted nuclei were counted on a hemocytometer to calculate 
nuclei density and then loaded onto the Chromium Controller 
(10X Genomics) for gel bead emulsion formation with ≈10 000 
nuclei loaded per sample for library preparation. After gel bead 
emulsion formation, library preparation was conducted accord-
ing to the manufacturer’s recommended protocol using the 
Chromium Next GEM Single Cell 3′ GEM, Library & Gel Bead 
Kit version 3.1. Libraries were sequenced on the NovaSeq 6000 
(Illumina) at 50 000 reads per nuclei resolution.
PCM1 Cardiomyocyte Nuclei Enrichment, 
RNA-Seq Library Preparation, and 
Sequencing
PCM1 nuclear enrichment, RNA extraction, library prepara-
tion, and sequencing were performed as described previously 
with minor modifications.12,13 Full details are provided in the 
Data Supplement.
PCM1+ Cardiomyocyte Bulk Assay for 
Transposase-Accessible Chromatin 
Sequencing Library Preparation and 
Sequencing
After PCM1 nuclei sorting and pelleting, Assay for Transposase-
Accessible Chromatin using sequencing (ATAC-seq) libraries 
were generated according to the methods described in a pre-
vious publication.14 Libraries were sequenced for 120 million 
paired-end reads on HiSeq2500 (Illumina).
Bioinformatics Analysis for SnRNA-Seq
The sequencing reads were mapped, processed, and counted 
using Cell Ranger (version 3.0.2), resulting in a table of unique 
molecular identifier counts for 33 939 genes for each of the 
9 samples. The number of cells captured per biological rep-
licate ranged from 1681 to 10 948, with a median of 5558. 
All subsequent analysis was performed using the R statisti-
cal programming language (version 3.6.0). The quality of the 
cells was assessed for each sample independently by examin-
ing the total number of cells, the distributions of total unique 
molecular identifier counts, the number of unique genes 
detected, and the proportions of ribosomal and mitochon-
drial content per cell.
For each developmental group (fetal, young, adult) we 
performed gene filtering, SCTransform normalization,15 data 
integration of the 3 biological replicates,16–18 data scaling, 
and graph-based clustering separately, using the R package 
Seurat (version 3.0.2). For gene filtering, mitochondrial and 
ribosomal genes were discarded, as well as genes that were 
not annotated. Genes that had at least 1 count in at least 20 
cells were retained for further analysis, assuming a minimum 
cluster size of 20 cells. All genes on the X and Y chromosomes 
were removed before clustering and all subsequent analysis. 
Data integration of the biological replicates for each group 
was performed using canonical correlation analysis with 30 
dimensions and 3000 integration anchors followed by data 
scaling. Clustering of the cells was performed with 20 princi-
pal components and resolution parameter set to 0.3 for fetal 
and young samples and 0.6 for adult samples. Taking this 
strategy, 22, 17, and 21 clusters were identified in the fetal, 
young, and adult samples, respectively.
For marker analysis, the counts were log2 transformed, 
adding a pseudocount of 0.5 proportional to the library size. 
Using the limma R package (version 3.40.2), marker genes 
were identified as significantly upregulated genes for each 
cluster using moderated t tests, accounting for the mean 
variance trend and using robust empirical Bayes shrinkage of 
the variances, followed by TREAT tests specifying a log-fold 
change threshold of 0.5 and false discovery rate (FDR) cutoff 
<0.0519-21. The marker genes, in conjunction with visualiza-
tions including violin plots, t-distributed stochastic neighbor 
embedding, and uniform manifold approximation, as well 
as projection plots, clustering trees,22 and heat maps show-
ing expression of previously published marker genes, were 
used to aid in interpretation of the clusters. Seven broad cell 
types were defined for fetal, young, and adult samples by 
combining clusters together that had similar gene expression 
profiles. In addition, a small population of erythroid cells in 
the fetal samples was identified. Marker analysis at the broad 
cell type level was performed as described earlier for each 
group separately, as well as for all samples across groups, 
confirming the broad cell type identities. Gene set testing to 
test for enrichment of REACTOME gene sets (https://www.
gsea-msigdb.org/gsea/msigdb/collections.jsp) and transcrip-
tion factor (TF) target sets was performed using CAMERA.23 
The ENCODE (Encyclopedia of DNA Elements) TF target sets 
were curated as described previously.13 Significant differences 
in cell type composition between groups was assessed using 
a propeller test from the speckle R package (https://github.
com/Oshlack/speckle).
Pseudobulk samples were created by summing the counts 
for each biological replicate for each cell type.24 The data were 
transformed using voom25 and differential expression analysis 
within each broad cell type performed using limma, testing 
for genes differentially expressed across the developmental 
trajectory, as well as sex differences within each time point. 
Robust empirical Bayes variance estimation was performed, 
and TREAT tests with a log-fold change threshold of 0.5 
identified significantly differentially expressed genes for each 
comparison at FDR <0.05. Gene set testing of the REACTOME 
and ENCODE TF targets sets was performed using CAMERA.
To identify subclusters of the broad cell type lineages, cells 
from all 9 biological replicates were integrated for each broad 
cell type separately. Cells that had <500 genes expressed 
and <2500 total unique molecular identifier counts were dis-
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was performed as before. The data were normalized, inte-
grated, scaled, and clustered (resolution parameter = 0.1) as 
described earlier. Marker analysis and gene set testing were 
performed. These analysis steps were repeated for each of 
the 7 broad cell types. For broad cell types with fewer cells, 
the number of principal components used for clustering was 
reduced (immune cells = 15 principal components, neural 
cells and smooth muscle cells = 10 principal components). 
Propeller tests were run to identify population shifts across 
development within the broad cell types.
PCM1+ Cardiomyocyte Bulk RNA-Seq and 
ATAC-Seq Bioinformatics Analyses
PCM1+ bulk RNA-seq and ATAC-seq bioinformatic analyses 
were conducted as described previously with minor modifica-
tions.13 Full details are provided in the Data Supplement.
Human-Induced Pluripotent Stem 
Cell–Cardiomyocyte Differentiation for 
ATAC-Seq
The human induced pluripotent stem cell (hiPSC) lines 
MCRIi001-A (male) and MCRIi004-A (female) were repro-
grammed by the iPSC Derivation Core Facility at the Murdoch 
Children’s Research Institute from the blood of healthy 
donors.26 Both lines were cultured as described previously.27 
See the Data Supplement Methods for a full description.
Human Embryonic Stem Cell–Derived 
Cardiomyocyte Differentiation, 
Extracellular Field Potential, and 
Impedance Analysis
The human embryonic stem cell (hESC) line HES3 NKX2-5eGFP/w 
(female) was used for functional studies in 2-dimensional mono-
layer cultures of human cardiomyocytes.28 Cardiomyocytes 
were cultured in maturation media and placed on the 
CardioExcyte plate reader (Nanion) for calibration. At least 12 
hours after calibration, baseline recordings were obtained, and 
the cells were then treated with the following conditions: 0.1% 
ethanol as a vehicle control, 1 µM hydrocortisone, 1 µM testos-
terone, or 10 µM progesterone. Another recording was made 
48 hours after treatment, and each well was then normalized 
to its baseline recording before comparisons were performed 
between groups. All conditions were electrically stimulated at 
1 Hz, and only samples that were definitively paced at 60±6 
beats per minute were included for downstream analyses. See 
Data Supplement Methods for a full description.
Human Cardiac Organoid Differentiation 
and Functional Analysis
Human cardiac organoids (hCOs) were generated as described 
previously using H9 human embryonic stem cells (female) 
until day 15.27, 29, 30 Over 4 days, hCOs were exposed to differ-
ent treatment conditions including 0.1% ethanol as a vehicle 
control, 10 µM progesterone, and 10 µM progesterone with 
10 µM mifepristone with treatment refreshed every 48 hours. 
hCOs were measured for functional parameters such as force, 
rate, 50% activation time, and 50% relaxation time as per 
previous publications.27,29
Statistical Analysis
All nonbioinformatics statistical analyses were performed 
using GraphPad Prism 8.1.1. For animal experiments, sample 
sizes were determined using predicted size of effects from 
previous work with an α value of 0.05 and a β value of 0.1, 
and animals were randomly assigned to experimental groups. 
For comparisons between 2 groups, a 2-tailed unpaired 
Student t test was used. For multiple group comparisons, a 
1-way ANOVA followed by Tukey posttest was used. For com-
parison between multiple groups with multiple variables, a 
2-way ANOVA followed by Sidak or Tukey posttest was used. 
For quantitative polymerase chain reaction validation of PCM1 
enrichment, nonparametric Wilcoxon matched-pairs signed-
rank test was performed on individual gene markers, because 
the data were not normally distributed and each PCM1+ sam-
ple was coupled to its respective PCM1– control. All data are 
presented as mean±SEM. Detailed statistical analysis methods 
and sample sizes are indicated in the figure legends. For all 
statistical analyses, *P≤0.05 and **P≤0.001.
Data Access
All data in the main and supplemental figures are associated 
with raw data and are available on reasonable request. All 
snRNA-seq, bulk RNA-seq, and ATAC-seq raw fastq.gz files 
have been deposited to the Gene Expression Omnibus under 
accession No. GSE156707. Comprehensive bioinformatics 
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RESULTS
Single-Cell Analysis Reveals Age- and 
Sex-Dependent Transcriptional Changes 
During Human Heart Development
To gain insight into the developmental mechanisms un-
derpinning human heart maturation, we transcriptionally 
profiled cardiac tissue samples isolated from the left ven-
tricle of healthy donor hearts at fetal, young, and adult 
stages of development (Figure  1A and Table V in the 
Data Supplement). Because intact cardiomyocytes cannot 
be readily dissociated from frozen heart tissue or sorted 
through microfluidic channels in conventional Drop-seq 
platforms for single-cell gene expression analysis,7,31 we 
adapted protocols for isolation of individual cardiac nu-
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SnRNA-seq of 54 140 single cardiac nuclei from fetal, 
young, and adult hearts revealed 8 major cell types with-
in the human left ventricle (Figure 1B and Figure I in the 
Data Supplement). Analysis of marker genes and gene 
ontology terms in these 8 clusters enabled discrimina-
tion of major cardiac cell types including cardiomyocytes, 
Figure 1. SnRNA-seq reveals age- and sex-dependent maturation of cardiac cells during human development.
A, Schematic of nuclei isolation for snRNA-seq, bulk RNA-seq, and ATAC-seq. B, UMAP plot of nuclei showing distinct clusters of cardiac cell types at differ-
ent stages of human heart development. C, Bar plot of cell type proportions for each biological replicate (f = fetal, y = young, a = adult, 1–3 denote biological 
replicate). D, MDS plot displaying pseudobulk profiles of cell types in samples. The largest projection of expression variation is shown on the x axis, and the second 
largest orthogonal projection is on the y axis. E, Bar plot of the number of DE genes in each cell type showing the number of DE genes that are progressively up-
regulated (red) or downregulated (blue) during human heart development from fetal to adult stages. F, Bar plot showing the number of DE genes between males 
and females across different cell types in fetal (gold), young (orange), and adult (maroon). G, GSEA reactome analysis of developmentally upregulated (left) and 
downregulated (right) genes for each cardiac cell type. Top 5 gene sets displayed for each cell type. ATAC-seq indicates Assay for Transposase-Accessible Chroma-
tin using sequencing; DE, differentially expressed; GSEA, gene set enrichment analysis; MDS, multidimensional scaling; snRNA-seq, single-nucleus RNA sequencing; 
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fibroblasts, endothelial cells, epicardial cells, immune cells, 
smooth muscle cells, and neural and erythroid cells (Fig-
ures II and III in the Data Supplement). With the excep-
tion of erythroid cells, which were only present in cardiac 
nuclear preparations from fetal hearts, all other major 
cardiac cell types were detected across all developmental 
time points (Figure IB in the Data Supplement). Cardiac 
maturation was associated with major shifts in cellular 
composition characterized by a significant expansion in 
the relative proportion of cardiac fibroblasts and immune 
cells in the postnatal human heart, accompanied by a 
significant decrease in the proportion of cardiomyocytes 
(Figure 1C, FDR<0.05, propeller test). As reported previ-
ously, we observed variation in individual sample con-
tributions to snRNA-seq clusters.7,32 All fetal cardiac cell 
types clustered distinctly from postnatal cells (Figure 1D), 
with the majority of differentially expressed genes during 
cardiac maturation accounted for by changes in cardio-
myocytes, epicardial cells, fibroblasts, and endothelial cells 
(Figure 1E). Statistically significant sex differences in the 
transcriptional profiles of all cardiac cell types were identi-
fied across all stages of development, with the majority of 
these differences observed in cardiomyocytes (Figure 1F). 
Cardiomyocyte maturation in humans was associated 
with repression of cell cycle genes and activation of meta-
bolic genes involved in oxidative phosphorylation and the 
respiratory electron transport chain (Figure 1G), which is 
consistent with well-described processes regulated during 
cardiac maturation in mammals.13 Maturation of nonmyo-
cyte populations was associated with increased interferon 
signaling capacity and responsiveness in fibroblasts, en-
dothelial cells, immune cells, and epicardial and neural 
cells (Figure 1G). In addition, 37 subclusters of cardiac cells 
were identified across the 7 major cell types (Figures IV, V, 
and VI in the Data Supplement), consistent with other re-
ports of heterogeneity and interindividual variation within 
human cardiac cell populations.7 For example, 7 subclus-
ters of cardiomyocytes were identified, including mitotic 
cardiomyocytes (cluster 2), which were more abundant 
in the fetal heart compared with postnatal human hearts 
(Figures VIA through VIC and VII in the Data Supplement). 
Overall, human heart development is characterized by a 
maturation trajectory in all cardiac cell types, with the larg-
est number of changes including sex differences occurring 
in cardiomyocytes.
Cardiomyocytes Undergo Profound 
Transcriptional Maturation in a Sex-
Dependent Manner During Human Heart 
Development
To further explore the degree to which sex differences 
contribute to the emergence of diverse cardiomyocyte 
transcriptional networks during cardiac maturation, we 
performed deep RNA sequencing of highly purified car-
diomyocyte nuclei on an expanded set of human cardiac 
tissue samples (n=21 samples including 10 males and 
11 females; Tables V and VI in the Data Supplement). 
Consistent with previous reports,12,13,33,34 PCM1-purified 
cardiomyocyte nuclei exhibited increased ploidy during 
cardiomyocyte maturation (Figures VIIIA and VIIIB in the 
Data Supplement) and were enriched for cardiomyocyte 
markers and depleted of nonmyocyte transcripts (Figure 
VIIIC in the Data Supplement). Unsupervised hierarchical 
clustering and principal coordinate analysis revealed dis-
tinct clusters of cardiomyocytes that could be separated 
on the basis of developmental stage and sex, with the 
majority of sex differences emerging in adulthood (Fig-
ure 2A and 2B). Consistent with our snRNA-seq analysis, 
cardiomyocyte maturation was associated with highly 
connected pathways linked to repression of cell cycle 
genes and activation of metabolic processes related to 
the tricarboxylic acid cycle and respiratory electron trans-
port chain (Figure 2C and Figure IXA through IXD in the 
Data Supplement). Bulk RNA-seq of PCM1-purified car-
diomyocyte nuclei identified thousands of differentially 
expressed genes among fetal, young, and adult cardio-
myocytes (Figure 2D) with strong overlap between dif-
ferentially expressed genes identified by bulk RNA-seq 
and snRNA-seq (Figure XA in the Data Supplement). Sex 
differences identified using snRNA-seq were confirmed 
and expanded using bulk RNA-seq of purified cardio-
myocyte nuclei (Figure XB in the Data Supplement). It is 
interesting to note that although broad cardiomyocyte 
maturation programs were shared between males and 
females, a large subset of genes (N=1647, FDR≤0.05) 
exhibited sexually dimorphic developmental regulation 
characterized by reciprocal regulation of genes during 
cardiomyocyte maturation in males and females (Fig-
ure 2E). Transcriptional networks that were induced in 
males but repressed in females during cardiomyocyte 
maturation were associated with chromatin organiza-
tion, histone modification, and RNA processing (Fig-
ure 2F). In contrast, transcriptional networks that were 
induced in females but repressed in males during cardio-
myocyte maturation were involved in vesicle-mediated 
transport (Figure  2F). Although some sex differences 
were apparent between male and female cardio-
myocytes at early stages of fetal development (N=35, 
FDR≤0.05, Figure 2G), a much larger number of differ-
entially expressed genes (N=2818, FDR≤0.05, Figure 2G) 
were identified in adulthood, and these were mostly in-
volved in the regulation of cytoskeleton organization, 
RNA processing, and cell adhesion (Figure 2H and Fig-
ure IXE in the Data Supplement). Sex differences at fetal 
stages of development were primarily attributed to X 
and Y chromosome–linked genes, whereas the major-
ity of differentially expressed genes in adulthood were 
autosomal (see gold circles for X- and Y-linked genes 
in Figure 2G). These results unveil sex-specific transcrip-





 http://ahajournals.org by on June 17, 2021
Sim et al Human Heart Maturation Is Influenced by Sex














Analysis of the Chromatin Accessibility 
Landscape Identifies TFs Associated With 
Human Cardiomyocyte Maturation
We next sought to identify potential transcriptional driv-
ers of sex-specific maturation programs by surveying the 
accessible chromatin landscape of developing cardio-
myocytes. Open chromatin regions were analyzed using 
the ATAC-seq on PCM1-purified nuclei. Fetal, young, 
adult, and hiPSC-derived cardiomyocytes composed of 
both male and female samples were profiled across all 
groups (n=27 samples in total, Tables V and VII in the 
Figure 2. Cardiomyocytes undergo sex-specific transcriptional maturation during human development.
A, Pearson correlation heat map of bulk RNA-seq showing distinct clustering of PCM1-purified cardiomyocytes from fetal versus young and adult samples. B, 
MDS plot illustrating the largest source of variation in the data are between fetal (gold circles) versus young (orange triangles) and adult (maroon squares) 
cardiomyocytes with some separation of female versus male (open versus closed) cardiomyocytes evident in adult samples. C, Cytoscape representation of GSEA 
reactome analysis of genes that are progressively upregulated (red) or downregulated (blue) during human cardiomyocyte maturation from fetal to adult stages. D, 
Mean-difference scatter plots highlighting differentially expressed genes (both sexes) for all comparisons including dynamically regulated genes (fetal>young>adult), 
fetal versus young, young versus adult, and fetal versus adult cardiomyocytes. Genes that are significantly upregulated (red) or downregulated (blue) are highlighted 
(FDR≤0.05). E, Log-fold change scatter plot of developmentally regulated genes (fetal versus adult) displaying reciprocal regulation during cardiomyocyte maturation 
in males and females. Genes that are upregulated in males and downregulated in females (blue), upregulated in females and downregulated in males (pink), or on 
chromosome X or Y (gold) are highlighted. F, Gene ontology analysis for genes that are upregulated in males and downregulated in females (blue) or upregulated 
in females and downregulated in males (pink). G, Mean-difference scatter plots comparing male versus female cardiomyocytes at fetal (left) and adult (right) 
stages. Genes that are upregulated in males (blue), upregulated in females (pink), or on chromosome X or Y (gold) are highlighted (FDR≤0.05). H, Gene ontology 
analysis of differentially expressed genes between adult male (blue) and female (pink) cardiomyocytes. An FDR≤0.05 using the correction procedure of Benjamini 
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Data Supplement). Principal coordinate analysis and 
unsupervised hierarchical clustering separated samples 
on the basis of developmental stage and sex with the 
majority of differences accounted for by hiPSC-derived 
cardiomyocytes compared with native cardiomyocytes 
(Figure 3A and 3B). Human cardiomyocyte maturation 
was associated with global shifts in chromatin acces-
sibility across 4707 genomic regions from midgesta-
tion to adulthood (Figure 3C). The majority (>99%) of 
these developmental changes in chromatin accessibil-
ity emerged between midgestation (19–20 weeks) and 
early childhood (<4 years) with very few distinguish-
able peaks identified between young and adult sam-
ples (Figure  3C). The distribution of ATAC-seq peaks 
across genomic features was comparable among fetal, 
young, and adult samples (Figure 3D). However, hiPSC-
derived cardiomyocytes were characterized by a greater 
proportion of ATAC-seq peaks across gene promoters 
(Figure 3D). The majority (≈70%) of differentially acces-
sible chromatin regions among fetal, young, and adult 
groups occurred across intronic and intergenic regions 
with ≈20% situated around gene promoters and ≈10% 
falling inside exons and transcription termination sites 
(Figure 3D). The distribution of ATAC-seq peaks across 
autosomes was comparable between male and fe-
male cardiomyocytes at all developmental stages (Fig-
ure XIA in the Data Supplement). As expected, open 
chromatin regions at gene promoters were strongly 
correlated with active gene transcription (Figure XIB in 
the Data Supplement). In accordance with previously 
published RNA-seq data from PCM1-enriched human 
cardiomyocyte nuclei34 and ATAC-seq data from adult 
human heart tissue from ENCODE, integration of our 
ATAC-seq and RNA-seq data sets validated known car-
diomyocyte maturation markers (Figure XIC in the Data 
Supplement). For example, cardiomyocyte maturation 
was associated with transcriptional repression and loss 
of chromatin accessibility around the promoters of 
TNNI1 and BMP5 (Figure XIC in the Data Supplement), 
as well as transcriptional activation and gain of acces-
sibility around the promoters of the metabolic genes 
PDK4 and PFKFB2 (Figure XIC in the Data Supplement). 
To identify putative TFs driving cardiomyocyte matura-
tion programs, we next surveyed accessible chroma-
tin regions for enriched TF motifs across all groups in 
our data set (Figure 3E). Accessible chromatin regions 
in hiPSC-derived cardiomyocytes were highly enriched 
for pluripotency TF binding motifs (Figure 3E), suggest-
ing that in vitro cardiac differentiation protocols do not 
completely remodel the genomic landscape of human 
pluripotent stem cells to differentiated cardiomyocytes. 
Comparison of fetal, young, and adult cardiomyo-
cytes revealed a progressive loss of accessibility around 
TF binding sites associated with cardiac development 
(GATA4, TBX20) and the cell cycle (E2F1, E2F4, and 
TEAD; Figure  3E). In contrast, cardiomyocyte matura-
tion was associated with a gain of accessibility around 
TF binding sites for steroid hormone nuclear receptors 
(glucocorticoid response element, androgen response 
element, and PGR), as well as TFs belonging to the 
AP1-JUN family (Figure 3E).
As expected, significant differences in ATAC-seq 
peak distribution across the X and Y chromosomes 
were noted for male and female samples across all 
groups (Figure XIA in the Data Supplement). Moreover, 
hundreds of differentially accessible chromatin regions 
(N=288, FDR≤0.05) were identified between adult male 
and female cardiomyocytes, with the majority of differ-
ences linked to sex chromosomes (see gold circles for 
X- and Y-linked regions in Figure 3F). Adult male-spe-
cific ATAC-seq peaks were characterized by a greater 
proportion of peaks across intronic regions, whereas fe-
males had a greater peak distribution across gene pro-
moters (Figure  3G). The majority of sex-specific open 
chromatin regions were not developmentally regulated 
(Figure 3H). However, open chromatin regions in adult 
male cardiomyocytes were highly enriched for steroid 
hormone nuclear receptors including androgen re-
sponse element, glucocorticoid response element, and 
PGR, whereas accessible chromatin regions in female 
cardiomyocytes were highly enriched for AP1-JUN mo-
tifs (Figure 3I). To confirm the putative role of steroid 
hormone nuclear receptors in cardiomyocyte matura-
tion, we analyzed the Tn5 insertion signal across all 
ATAC-seq peaks, which confirmed distinct TF foot-
prints for androgen response element, glucocorticoid 
response element, and PGR in open chromatin regions 
of adult versus fetal and hiPSC-derived cardiomyocytes 
(Figure  3J). Moreover, interrogation of differentially 
open chromatin regions during cardiomyocyte matura-
tion revealed considerable overlap between TF binding 
sites for the androgen response element, glucocorticoid 
response element, and PGR (Figure  3K). Collectively, 
these results suggest that steroid hormone nuclear re-
ceptors drive sex-specific transcriptional programs asso-
ciated with cardiomyocyte maturation in humans.
Progesterone Receptor Controls Sex-
Specific Transcriptional Programs 
Associated With Human Cardiomyocyte 
Maturation
Given the well-established functions of sex steroids 
and steroid hormone nuclear receptors in maturation 
of reproductive tissues during development,35 we sub-
sequently focused on their potential roles as mediators 
of sex-specific differences arising during cardiomyocyte 
maturation. Androgen receptor (AR) and progesterone 
receptor (PGR) gene expression levels increased dur-
ing cardiomyocyte maturation, although expression 
levels did not differ between male and female cardio-
myocytes (Figure 4A and 4B). Single-cell analysis con-
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Figure 3. Cardiomyocyte maturation is associated with sex-specific chromatin remodeling around steroid hormone nuclear receptor motifs during 
human heart development.
A, MDS plot shows that the largest source of variation in the ATAC-seq data are between the hiPSC-CM (apricot) and fetal (gold), young (orange), and adult 
(maroon) samples. Female samples are indicated with open plotting characters and male closed. B, Pearson correlation heat map of bulk ATAC-seq illustrat-
ing distinct clustering of PCM1-purified cardiomyocytes from hiPSC-CM versus fetal, young, and adult samples. C, Mean-difference scatter plots of differentially 
regulated open chromatin regions for all comparisons including dynamically regulated regions (fetal>young>adult), fetal versus young, young versus adult, and 
fetal versus adult cardiomyocytes. Regions that are more accessible (red) or less accessible (blue) are highlighted (FDR≤0.05). D, Genomic distribution of ATAC-seq 
peaks in each group. E, TF motif predictions for open chromatin regions in hiPSC-CM, fetal, young, and adult cardiomyocytes. Circle size and color denotes the 
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during postnatal maturation, whereas AR expression 
was below the threshold of detection in our snRNA-seq 
analysis (Figure XIIA in the Data Supplement). The gene 
encoding the glucocorticoid receptor nuclear receptor 
subfamily 3 group C member 1 (NR3C1), was down-
regulated in cardiomyocytes during cardiac maturation 
(Figure 4A and 4B and Figure XIIA in the Data Supple-
ment). It is interesting to note that consistent with well-
known species differences between mice and humans 
in the developmental regulation of sarcomeric protein 
isoforms during cardiomyocyte maturation,36 we also 
observed species differences in the developmental reg-
ulation of steroid hormone nuclear receptors (Figure 4A 
and Figure XIIB in the Data Supplement). In contrast 
with the relatively high expression of the AR and PGR 
in human cardiomyocytes (Figure  4A), Ar was barely 
detectable and Pgr was undetectable in mouse cardio-
myocytes (Figure XIIB in the Data Supplement). These 
findings reveal potentially important species differences 
in the regulation of cardiomyocyte maturation between 
mice and humans.
To assess the potential effect of steroid hormones 
on human cardiomyocyte function, we screened a 
number of steroids for potential effects on cardiac 
contractility using cardiomyocytes differentiated from 
the HES3 NKX2-5eGFP/w human embryonic stem cell 
line.37 Standard 2-dimensional monolayers of human 
cardiomyocytes were treated with vehicle (ethanol), 
hydrocortisone (cortisol), testosterone, or progester-
one (ligands for NR3C1, AR, and PGR, respectively), 
and cardiomyocyte electrophysiology and contrac-
tility were concurrently recorded using extracellular 
field potential and impedance measurements. Initial 
screening of steroid hormones revealed a positive 
inotropic effect of progesterone, which increased 
contractile amplitude, upstroke velocity, and relax-
ation velocity (Figure 4C). We subsequently validated 
this finding in 3-dimensional hCOs cultured under 
maturation conditions from an independent human 
embryonic stem cell line (H9), which confirmed a sig-
nificant increase in cardiac force production in the 
presence of progesterone (Figure 4D). It is important 
to note that the positive inotropic effect of progester-
one was abolished in the presence of the PGR antago-
nist mifepristone (RU-486; Figure 4D). The spontane-
ous contraction rate of hCOs was also reduced in the 
presence of progesterone, and this effect was abro-
gated in the presence of RU-486 (Figure 4D). These 
data indicate that PGR activation augments cardiac 
contractility and reduces the spontaneous contraction 
rate of hCOs, which are consistent with a putative 
role in cardiomyocyte maturation.
In contrast with human cardiomyocytes, the PGR is 
not expressed in adult mouse cardiomyocytes (Figure 
XIIB in the Data Supplement). Accordingly, RNA-seq 
analysis of Pcm1-purified cardiomyocyte nuclei from 
PRKO mice revealed that the transcriptional program 
of adult mouse cardiomyocytes was not affected by 
genetic deletion of Pgr (Figure XIIC and XIID in the 
Data Supplement). To evaluate the potential effects 
of human PGR activation on cardiomyocyte matura-
tion in vivo, we performed a gain-of-function experi-
ment in mice (Figure 4E). The human PGR was deliv-
ered to neonatal mice using adeno-associated virus 
(AAV) serotype 6, which displays very high tropism 
for cardiac muscle in vivo38 and results in preferential 
transduction of cardiomyocytes.39 Expression of the 
human PGR was confirmed in adult cardiomyocytes 
from mice treated with AAV-PGR compared with mice 
treated with an AAV empty vector control (Figure 4F). 
RNA-seq of purified adult cardiomyocytes from AAV-
PGR and AAV empty vector control–treated mice dem-
onstrated distinct clustering of samples on the basis 
of treatment and sex (Figure  4G). Expression of the 
human PGR during cardiomyocyte maturation in vivo 
altered the expression of 269 genes in adult cardio-
myocytes (Figure  4H). Human PGR activation in vivo 
was associated with sex-specific activation of tran-
scriptional networks involved in fatty acid oxidation, 
lipid metabolism, tricarboxylic acid cycle, and respira-
tory electron transport chain (Figure 4H through 4J). 
More than 40% of PGR-regulated genes were also 
induced during cardiomyocyte maturation in mice,13 
and these were broadly associated with lipid trans-
port (Figure 4K). Moreover, a subset of these genes 
associated with activation of lipid metabolic pro-
cesses, including acyl-CoA metabolism, were also 
regulated during human cardiomyocyte maturation 
(Figure 4K). Thus, the PGR modulates human cardio-
myocyte contractility and transcriptionally regulates 
metabolic networks associated with cardiomyocyte 
maturation in a sex-specific manner.
Figure 3 Continued. versus female cardiomyocytes. Regions that are more accessible in females (pink), more accessible in males (blue), or on chromosome X or 
Y (gold) are highlighted. G, Genomic distribution of differentially regulated open chromatin regions in adult male and female cardiomyocytes. H, Bar plot showing 
number of developmentally regulated ATAC-seq peaks (fetal = gold, adult = maroon) for differentially open chromatin regions in adult male (M) and female (F) 
cardiomyocytes. I, Bar plot showing significantly enriched TF binding motifs in differentially regulated open chromatin regions between adult male (blue) and 
female (pink) cardiomyocytes. J, TF footprinting for ARE, GRE, and PR confirming increased binding to open chromatin regions in adult (maroon) and young 
(orange) cardiomyocytes versus fetal (gold) and iPSC-derived (apricot) cardiomyocytes. Venn diagram showing shared and unique transcription factor binding 
sites for ARE, GRE, and PR in open chromatin regions of adult cardiomyocytes compared with fetal. An FDR≤0.05 with the correction procedure of Benjamini and 
Hochberg was used. ARE indicates androgen response element; ATAC-seq, Assay for Transposase-Accessible Chromatin using sequencing; FDR, false discovery 
rate; GRE, glucocorticoid response element; hiPSC-CM, human induced pluripotent stem cell cardiomyocyte; iPSC, induced pluripotent stem cell; MDS, multidi-
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Figure 4. The progesterone receptor augments cardiac contractility and activates sex-specific metabolic networks associated with cardiomyocyte 
maturation.
A, Gene expression (log CPM reads) showing developmental regulation of sarcomeric genes (MYH6, MYH7), cardiac TFs (NKX2.5), and nuclear steroid hormone 
receptors (AR, NR3C1, PGR) during human cardiomyocyte maturation. Data are mean±SEM. *FDR≤0.05; **FDR≤0.001. B, Gene expression (log CPM reads) for 
nuclear steroid hormone receptors (AR, GR, PGR) in male (blue) versus female (pink) cardiomyocytes at fetal and adult stages. Data are mean±SEM. *FDR≤0.05, 
**FDR≤0.001. C, Progesterone treatment increases contractile force of 2-dimensional hESC-CMs. Dot plots showing baseline-normalized functional readouts for 
HES3 NKX2-5eGFP/w cardiomyocytes cultured in MM and treated with vehicle (V: 0.1% ethanol), glucocorticoids (G: 1 µM hydrocortisone), testosterone (T: 1 µmol/L 
of testosterone), or progesterone (P: 10 µmol/L of progesterone). Data are presented as fold change for n=5 independent experiments with >27 replicates per 
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Sex steroids play an important role in regulating car-
diac physiology and cardiovascular disease outcomes. 
However, studies to date have almost exclusively fo-
cused on the contributions of estrogen and testoster-
one.10 Progesterone via PGR is traditionally associated 
with functions in female reproductive physiology, in-
cluding essential roles in ovulation, uterine receptivity, 
and pregnancy maintenance.40 Our study reveals a pre-
viously unappreciated role for progesterone in human 
cardiomyocyte maturation in both males and females, 
including the establishment of sex-specific transcrip-
tional programs associated with oxidative metabolism 
in cardiomyocytes. Progesterone-driven alterations in 
cardiomyocyte metabolism might contribute to previ-
ously described effects of progesterone on cardiac hy-
pertrophy and protein synthesis in female rats associ-
ated with cardiac adaptations during pregnancy.41–43 
It is interesting to note that progesterone levels tran-
siently increase 20-fold in the luteal phase44 and 300-
fold during pregnancy (or can be chronically elevated 
with progestin-based oral contraceptives). However, 
serum progesterone levels are comparable in males and 
females outside the luteal phase of the reproductive 
cycle,45 suggesting that progesterone may also regu-
late cardiac physiology in males. These findings raise 
the possibility that fluctuating progesterone ligand, in 
combination with sex-specific DNA binding of PGR in 
cardiomyocytes, contributes to sex-based differences in 
cardiovascular health. Given the widespread prevalence 
of cardiovascular disease in children and adults world-
wide,46,47 it will be important to determine whether pro-
gesterone signaling can be therapeutically targeted to 
modify sexually dimorphic disease outcomes in the fu-
ture. In addition, our findings reveal that human heart 
development is associated with profound maturation of 
all cardiac cell lineages from fetal development to adult-
hood, which is consistent with previous observations in 
rodents.13 It is currently unclear whether progesterone 
plays a similar role in postnatal maturation of other 
cardiac lineages, although it is tempting to speculate 
that PGR may also regulate development of cardiac im-
mune cells given that it is upregulated in this lineage 
during human heart maturation (Figure XII in the Data 
Supplement). Additional studies are required to define 
the biological functions of progesterone during cardiac 
development in diverse lineages including characteriza-
tion of direct PGR targets and underlying mechanisms 
of action. Given the species differences reported here, 
as well as recent studies highlighting the prevalence 
of species differences in the regulation of sex-specific 
gene expression programs,48 it will be critical to dissect 
such mechanistic biology in humans. However, study-
ing human heart maturation will require ongoing re-
finement of organoid technologies to better reflect the 
complexity of diverse cell lineages in the human heart. 
Moreover, it is important to recognize the limitations 
of working with primary, nondiseased human tissue 
samples, which are difficult to obtain and could be in-
fluenced by unintended surgical biases, including slight 
variations in sampling from different anatomic regions. 
It is expected that our results will inform more detailed 
assessments of spatiotemporal variation in gene ex-
pression at the single-cell level and propel studies with 
larger cohorts to determine the roles of age, sex, and 
ancestry on normal human heart development. To this 
end, the key resource data sets outlined in this study 
provide a blueprint defining sex differences in human 
heart development and a framework for understand-
ing mechanisms underpinning the acquisition of adult 
cardiac cell identity.
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